|
Market Closed -
Bombay S.E.
05:26:00 2026-11-06 am EST
|
5-day change | 1st Jan Change | ||
| 92.00 INR | -4.96% |
|
-19.09% | +124.01% |
| Market Cap | 50.41B 536M 481M 440M 401M 756M 780M 5.3B 2.11B 26.9B 2.01B 1.97B 84.92B | P/E 2025 |
21.8x | P/E 2026 | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 51.95B 553M 496M 453M 414M 779M 804M 5.46B 2.18B 27.72B 2.07B 2.03B 87.51B | EV / Sales 2025 |
1.45x | EV / Sales 2026 | 1.11x |
| Free-Float |
57.95% | Yield 2025 |
0.42% | Yield 2026 | 0.59% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| MOREPENLAB | Delayed | |
NSE India S.E.
| MOREPENLAB | Delayed |
| 1 day | -4.96% | ||
| 1 week | -19.09% | ||
| Current month | -19.09% | ||
| 1 month | -36.00% | ||
| 3 months | +15.75% | ||
| 6 months | +111.20% | ||
| Current year | +124.01% |
| 1 week | 92 |  | 108.05 |
| 1 month | 92 | | 148.25 |
| Current year | 33.44 | | 150.8 |
| 1 year | 33.44 | | 150.8 |
| 3 years | 33.44 | | 150.8 |
| 5 years | 23.65 | | 150.8 |
| 10 years | 7.21 | | 150.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 2026-06-30 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 1992-01-31 |
| Director of Finance/CFO | 59 | 2002-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 1992-01-31 |
Sanjay Suri
BRD | Director/Board Member | 58 | 2019-08-12 |
| Director/Board Member | 58 | 2019-08-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.96% | -19.09% | +93.93% | +157.20% | 536M | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,206B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 665B | |
| +1.07% | -1.21% | +32.99% | +106.31% | 515B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 381B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 307B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 289B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 207B | |
| Average | -0.57% | -3.29% | +45.76% | +84.63% | 418.03B | |
| Weighted average by Cap. | -0.05% | -1.96% | +42.25% | +88.39% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 18.12B 193M 173M 158M 144M 272M 280M 1.9B 759M 9.67B 723M 708M 30.52B | 18.06B 192M 172M 157M 144M 271M 279M 1.9B 757M 9.63B 721M 706M 30.42B |
| Net income | 1.18B 12.56M 11.26M 10.29M 9.39M 17.7M 18.26M 124M 49.46M 630M 47.13M 46.11M 1.99B | 949M 10.09M 9.05M 8.27M 7.55M 14.23M 14.68M 99.72M 39.76M 506M 37.88M 37.07M 1.6B |
| Net Debt | -928K -9.87K -8.85K -8.09K -7.39K -13.92K -14.36K -97.54K -38.89K -495K -37.05K -36.26K -1.56M | 1.54B 16.36M 14.67M 13.41M 12.24M 23.06M 23.79M 162M 64.46M 821M 61.41M 60.09M 2.59B |
Employees
1,919
Sector
Pharmaceuticals
Calendar
Nov. 13
Earnings release - Q2 2027
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | ₹92.00 | -4.96% | 1,053,445 |
| 26-11-05 | ₹96.80 | -3.44% | 902,007 |
| 26-11-04 | ₹100.25 | -2.34% | 757,588 |
| 26-11-03 | ₹102.65 | -5.00% | 40,442 |
| 26-11-02 | ₹108.05 | -4.97% | 54,119 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
